Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

Making the News

 

PE-owned labs refinance

Two German PE-backed lab groups have taken on new long-term loans in the past couple of months, HBI explores. 

All change at IHH as CEO departure announced

Pan-Asian hospital group IHH Healthcare has announced its CEO will change at the end of 2019, a refinancing of up to $250m of non-Lira debt and its Fortis deal boosted Q1 2019 results, while its Turkish subsidiary Acibadem is reportedly eyeing an investment in London.

NHS Trust launches B2C blood tests

An NHS England Trust has launched a not-for-profit B2C blood testing service in direct competition with the for-profit market.

Clarity on prices and quality? Sort of

Private Healthcare Information Network (Phin) has published data on consultant physician fees in the private sector in the UK for the first time. So how close are we to really clear comparisons on price and quality between for-profit operators and on quality between the for-profit and NHS?

French lab market contracted in 2018

The French lab market contracted by 0.5% in 2018 as its public payor (CNAM) cut the national tariff to offset volume increases. HBI reveals how the country's largest groups faired.

What is the emerging markets landscape like post-Abraaj?

With several significant withdrawals by developed markets operators and the collapse of Abraaj in 2018, what does the emerging markets investment landscape look like? Investors focusing on Asia and Latin America discussed the challenges and opportunities at HBI 2019.

Find Us